Upcoming Webinars

Subvisible Particles Matter, Developments in Regulations and Low Volume Methods

Presented by Dr Satish K Singh, Lonza
26th July 2018


Next generation processes: What model works the best in Asia?

Presented by Ravishankar Kasturi, Vice President, Head of Manufacturing & Process Development, Reliance Life Sciences
09th August 2018


Mixed mode Chromatography in Purifying biologics – Overview

Presented by Vivek Halan, Senior Scientific manager, Zumutor Biologics Pvt Ltd
13th August 2018


Is India Anywhere Closer to Implementing Continuous Bioprocessing

Presented by Narasimha Rao Nedunuri, Managing Director of CLONZ
16th August 2018


Implementing CMC Strategies for scale-up operations in biologics manufacturing

Presented by Dr Anita Krishnan, Principal Scientist Lupin Ltd
20th August 2018


Material Understanding for Continuous Manufacturing of Solid Dosage Forms

Presented by Dr Yifan Wang, Regulatory Research Scientist, FDA CDER
23rd August 2018


Project and Portfolio Management as a key tool to manage continuous improvement in bio-pharma manufacturing

Presented by Gloria Gadea-Lopez, Ph.D.and Melvin Santos, Shire
06th September 2018


Efficiency by Design – Case Study for a Hybrid Clinical Manufacturing Facility

Presented by Dr Sourav Kundu, Senior Director, Process Development and Clinical manufacturing, Teva Pharmaceuticals
12th September 2018


Advanced process development using automated micro bioreactors shortens timelines and provides process solutions for a rapid scale up

Presented by Presented by Dr. Jincai Li, Vice President of WuXi Biologics and Liang Tang, PhD, Vice President of WuXi Biologics
14th September 2018


DSF and FTIR as complementary methods for the identification and characterization of vaccine products

Presented by Marina Kirkitadze, Deputy Director, Head of Biophysics & Conformation Unit, Analytical R&D Biochemistry, Sanofi Pasteur and Rina Dukor, President, BioTools
18th September 2018


Developability Assessment of Therapeutic Proteins – A Toolbox for Tackling Increasing Complexity

Presented by Thorsten Lorenz, Team Head Developability Assessment Biologics, Novartis
27th September 2018


Impact of Depth Filtration on Disulfide Bond Reduction during Downstream Processing of Monoclonal Antibodies from CHO Cell Cultures

Presented by Brian O' Mara, Senior Research Scientist I, Bristol-Myers Squibb
08th October 2018


Extractables and leachables testing using a Quality Risk Management approach

Presented by Dhaval Tapiawala, Principal Scientist, Pfizer
17th October 2018


Application of Multivariate Data Analysis for Process Diagnostic and Root Cause Analysis

Presented by Ramila Peiris, Ph.D., Manager, Process Modelling and Process Analytical Technology, Sanofi Pasteur
23rd October 2018


Advances and Challenges in Vaccine Development and Manufacture

Presented by Tony D'Amore, Vice Preseident, Product Research & Development, Sanofi Pasteur
02nd November 2018


Regulatory Approval of Three Rapid Microbiological Methods for MACI Product Release

Presented by John Duguid Senior Director, Research & Development at Vericel Corporation
08th November 2018


Evolve Manufacturing Processes by Implementing Disruptive Technologies

Presented by Presented by Yuyi Shen, Principal Scientist, Grifols
19th November 2018


Reducing Microbiological Risk and Using Quality Tools in the Pharmaceutical Industry

Presented by Don Singer Manager, Steriles Microbiology, for GlaxoSmithKline R&D
09th January 2019


Challenges faced by the end users during the qualification of Single Use System

Presented by Ben Jeyaretnam (Ph. D., MBA), E&L Analytics Lead, Sanofi, Swiftwater
14th January 2019


mAb Industry in China : Biosimilars vs Innovative Biologics

Presented by Dr. Joe X Zhou, CEO, Genor Biopharma, Walvax Bio Group and Floris De Smet, Sartorius Stedim Biotech
15th January 2019


Single Use Manufacturing within the Bristol-Myers Squibb Manufacturing Network – Preparing for Commercial Production

Presented by Lance Marquardt, Associate Director - Upstream Processing for Hopewell Clinical Manufacturing at Bristol-Myers Squibb and  Sara Bell, Senior Marketing Manager for Merck’s single-use product portfolio
17th January 2019


Overcoming Downstream Bottlenecks In The Upscaling Process

Presented by Dr. Dakshesh Mehta, Associate Vice President and Head of Bioprocess Group at Biotech & Genomics division, Wockhardt Research Center
17th January 2019


Extractables from Single-Use Bioreactors/Bags and Impact on Cell Culture Performance

Presented by Yasser Nashed-Samuel, Principal Scientist at Amgen
22nd January 2019


Quality Risk Management In Implementing New Bioprocess Technology

Presented by Dhaval Trivedi Associate Vice President-Regulatory Affairs at Stelis Biopharma
24th January 2019


Raw Material Lot Variability Challenges During Manufacturing of Biosimilars mab

Presented by Sekhar Reddy, DSP Lead for Biosimilars at Biocon MSAT
25th January 2019


Quality-By-Design in Spray Drying Processes – Transfer Lab to Production

Presented by Sune Klint Andersen and Filipe Gaspar, Hovione FarmaCiência
19th February 2019


Host Cell Protein Characterisation and Mass Spectrometry Strategies

Presented by Xuezhi Bi, Group Leader (Proteomics) /Senior Scientist, Bioprocessing Technology Institute, A*STAR
19th February 2019


Effect of Cell Culture Process Change from Fed-batch to Continuous on Productivity and Product Quality

Presented by Ru Zang, Senior Process Engineer of Biological Process Development at Momenta Pharmaceuticals
25th February 2019


Challenges in the Development of Continuous Processes for Vaccines

Presented by Danny Vellom of Sanofi Pasteur Biologics, Inc.
04th March 2019


Lifecycle management of single use technologies

Presented by Francis Verhoeye, Director Single Use Technologies, GSK Vaccines
05th March 2019


Risk Based Approaches to Use of Closed Systems in Renovations of Existing Biopharma API Facilities

Presented by Lars Hovmand-Lyster, Senior Engineering specialist in Novo Nordisk Global Project Office (GPO) Engineering management department
05th March 2019


From Early Stage to Late Stage Development: How to Characterize a Perfusion-based Vaccine Production Process Using QbD?

Presented by Perrine Rouel, Scientist - Up Stream Processing, The Janssen Pharmaceutical Companies of Johnson & Johnson
07th March 2019


Achieving Seamless Scale-Up and Technology Transfer – A Case Study in Single-Use Bioreactors

Presented by Ying Wang, Ph.D., Senior Scientist I, Manufacturing Sciences, AbbVie Bioresearch Center
11th March 2019


Understanding the Propensity of Sequence Variants During Cell Line and Culture Process Development

Presented by Dr. Lisa Marzilli, Associate Research Fellow and group leader at Pfizer, USA
18th March 2019


Transformational Science: Moving from Challenges of High Concentration Protein Formulations Development to Meet the Needs of High Potent Bispecifics

Presented by Sachin Dubey, Ph.D., Head of Formulation and Analytical Development at Glenmark Pharmaceuticals SA
19th March 2019